Padma Sampath

1.2k total citations
19 papers, 843 citations indexed

About

Padma Sampath is a scholar working on Oncology, Genetics and Immunology. According to data from OpenAlex, Padma Sampath has authored 19 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Genetics and 9 papers in Immunology. Recurrent topics in Padma Sampath's work include CAR-T cell therapy research (13 papers), Virus-based gene therapy research (12 papers) and Immunotherapy and Immune Responses (6 papers). Padma Sampath is often cited by papers focused on CAR-T cell therapy research (13 papers), Virus-based gene therapy research (12 papers) and Immunotherapy and Immune Responses (6 papers). Padma Sampath collaborates with scholars based in United States, China and India. Padma Sampath's co-authors include Steve H. Thorne, Weizhou Hou, Juan J. Rojas, Stephen H. Thorne, David L. Bartlett, Hannah Chen, Mark E. O’Malley, Paweł Kaliński, Rachel Sikorski and Jun Li and has published in prestigious journals such as Journal of Clinical Investigation, Cancer Cell and Clinical Cancer Research.

In The Last Decade

Padma Sampath

19 papers receiving 833 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Padma Sampath 597 517 327 280 112 19 843
Roshni Ravindranathan 805 1.3× 727 1.4× 432 1.3× 337 1.2× 157 1.4× 17 1.1k
Laura Evgin 639 1.1× 646 1.2× 261 0.8× 378 1.4× 121 1.1× 28 987
Mari Hirvinen 550 0.9× 651 1.3× 236 0.7× 361 1.3× 196 1.8× 19 878
Juan J. Rojas 575 1.0× 731 1.4× 170 0.5× 455 1.6× 196 1.8× 23 967
Murielle Gantzer 400 0.7× 620 1.2× 209 0.6× 544 1.9× 77 0.7× 13 915
Sari Pesonen 629 1.1× 734 1.4× 213 0.7× 448 1.6× 206 1.8× 24 947
Suvi Parviainen 436 0.7× 478 0.9× 160 0.5× 223 0.8× 118 1.1× 20 594
Margaret R. Duffy 445 0.7× 500 1.0× 134 0.4× 386 1.4× 83 0.7× 25 705
Jacqueline Kintz 252 0.4× 429 0.8× 118 0.4× 331 1.2× 104 0.9× 11 618
Johanna K. Kaufmann 551 0.9× 497 1.0× 325 1.0× 451 1.6× 90 0.8× 26 1.0k

Countries citing papers authored by Padma Sampath

Since Specialization
Citations

This map shows the geographic impact of Padma Sampath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Padma Sampath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Padma Sampath more than expected).

Fields of papers citing papers by Padma Sampath

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Padma Sampath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Padma Sampath. The network helps show where Padma Sampath may publish in the future.

Co-authorship network of co-authors of Padma Sampath

This figure shows the co-authorship network connecting the top 25 collaborators of Padma Sampath. A scholar is included among the top collaborators of Padma Sampath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Padma Sampath. Padma Sampath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Li, Feng, Yuqiao Sheng, Padma Sampath, et al.. (2020). CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency. Journal for ImmunoTherapy of Cancer. 8(1). e000131–e000131. 90 indexed citations
2.
Hou, Weizhou, Padma Sampath, Juan J. Rojas, & Steve H. Thorne. (2016). Oncolytic Virus-Mediated Targeting of PGE 2 in the Tumor Alters the Immune Status and Sensitizes Established and Resistant Tumors to Immunotherapy. Cancer Cell. 30(1). 108–119. 92 indexed citations
3.
Rojas, Juan J., Padma Sampath, Braulio Bonilla, et al.. (2016). Manipulating TLR Signaling Increases the Anti-tumor T Cell Response Induced by Viral Cancer Therapies. Cell Reports. 15(2). 264–273. 29 indexed citations
4.
Rojas, Juan J., Padma Sampath, Weizhou Hou, & Steve H. Thorne. (2015). Defining Effective Combinations of Immune Checkpoint Blockade and Oncolytic Virotherapy. Clinical Cancer Research. 21(24). 5543–5551. 118 indexed citations
5.
Thorne, Steve H. & Padma Sampath. (2015). Novel therapeutic strategies in human malignancy: combining immunotherapy and oncolytic virotherapy. PubMed. 4. 75–75. 15 indexed citations
6.
Zhang, Ming, Subhasish Chakraborty, Padma Sampath, et al.. (2015). Fluoromodule-based reporter/probes designed for in vivo fluorescence imaging. Journal of Clinical Investigation. 125(10). 3915–3927. 24 indexed citations
7.
Hou, Wenxiu, et al.. (2014). Manipulating the expression of chemokine receptors enhances delivery and activity of cytokine-induced killer cells. British Journal of Cancer. 110(8). 1992–1999. 15 indexed citations
8.
Hou, Weizhou, Hannah Chen, Juan J. Rojas, Padma Sampath, & Stephen H. Thorne. (2014). Oncolytic vaccinia virus demonstrates antiangiogenic effects mediated by targeting of VEGF. International Journal of Cancer. 135(5). 1238–1246. 54 indexed citations
10.
Tang, Hong, Padma Sampath, Xinmin Yan, & Stephen H. Thorne. (2013). Potential for enhanced therapeutic activity of biological cancer therapies with doxycycline combination. Gene Therapy. 20(7). 770–778. 18 indexed citations
11.
Chen, Hannah, Padma Sampath, Weizhou Hou, & Stephen H. Thorne. (2013). Regulating Cytokine Function Enhances Safety and Activity of Genetic Cancer Therapies. Molecular Therapy. 21(1). 167–174. 25 indexed citations
12.
Li, Jun, Mark E. O’Malley, Padma Sampath, et al.. (2012). Expression of CCL19 from Oncolytic Vaccinia Enhances Immunotherapeutic Potential while Maintaining Oncolytic Activity. Neoplasia. 14(12). 1115–IN1. 53 indexed citations
13.
Sampath, Padma, Jun Li, Weizhou Hou, et al.. (2012). Crosstalk Between Immune Cell and Oncolytic Vaccinia Therapy Enhances Tumor Trafficking and Antitumor Effects. Molecular Therapy. 21(3). 620–628. 42 indexed citations
14.
Sikorski, Rachel, et al.. (2011). Modulation of NKG2D-ligand Cell Surface Expression Enhances Immune Cell Therapy of Cancer. Journal of Immunotherapy. 34(3). 289–296. 54 indexed citations
15.
Li, Jun, Mark E. O’Malley, Julie Urban, et al.. (2011). Chemokine Expression From Oncolytic Vaccinia Virus Enhances Vaccine Therapies of Cancer. Molecular Therapy. 19(4). 650–657. 115 indexed citations
16.
O’Gorman, William, Padma Sampath, Erin F. Simonds, et al.. (2010). Alternate Mechanisms of Initial Pattern Recognition Drive Differential Immune Responses to Related Poxviruses. Cell Host & Microbe. 8(2). 174–185. 24 indexed citations
17.
Thorne, Stephen H., Padma Sampath, Tobi Schmidt, et al.. (2010). Targeting Localized Immune Suppression Within the Tumor Through Repeat Cycles of Immune Cell-oncolytic Virus Combination Therapy. Molecular Therapy. 18(9). 1698–1705. 41 indexed citations
18.
Sivakumar, Pitchumani, Padma Sampath, & Gobinath Chandrakasan. (1999). Collagenolytic metalloprotease (gelatinase) from the hepatopancreas of the marine crab, Scylla serrata. Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology. 123(3). 273–279. 25 indexed citations
19.
Sampath, Padma & Gowri Chandrakasan. (1998). Physiological and nutritional factors affecting biosynthesis of extracellular protease by Streptomyces spp. G157.. PubMed. 21(1). 55–63. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026